NEW YORK, Dec. 3—MDL Information Systems announced Monday that it will provide software and informatics systems for NiKem Research Srl, the medicinal chemistry spinoff of GlaxoSmithKline’s former R&D center in Milan, Italy.

NiKem will use MDL’s applications in all stages of drug discovery research, including reagent selection, assay design and biological data capture, storage and analysis, chemical data searching, and chemical registration.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.